JAK2 and metabolic dysfunction-associated steatotic liver disease: Additionally, the study by Li et al. further confirmed that recombinant human HGF can inhibit inflammatory responses and improve liver function in mice with non-alcoholic fatty liver disease by promoting the phosphorylation of JAK2-STAT3 [10].